1000 Participants Needed

Screening Tool for Substance Abuse

(TAPS-ESP Trial)

MB
BM
Overseen ByBrittany Meredith, Masters
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Baylor Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.

Research Team

KS

Katherine Sanchez, PhD

Principal Investigator

Baylor Scott and White Research Institute

Eligibility Criteria

This trial is for Spanish-speaking adults who are current patients at the clinic and can read Spanish. It's designed for those seeking screening and treatment for substance use, including tobacco, alcohol, prescription drugs, or other illicit substances.

Inclusion Criteria

Ability to read Spanish
Current patient of the clinic
I am 18 years old or older.
See 1 more

Exclusion Criteria

I cannot use an iPad by myself because of physical limitations.
Inability to comprehend or read Spanish
I am unable to understand and give consent for treatment.

Treatment Details

Interventions

  • TAPS-ESP
Trial OverviewThe study aims to validate the TAPS-ESP as a tool in primary care settings for identifying and assessing substance use issues. Participants will self-administer this screening tool on an iPad.
Participant Groups
2Treatment groups
Active Control
Group I: Self-Administration followed by Interviewer-AdministeredActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish
Group II: Interviewer-Administered followed by Self-AdministrationActive Control1 Intervention
Screening and validation of assessment tool translated into Spanish

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

COG Analytics

Collaborator

Trials
4
Recruited
1,200+